The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 4, 2007, Pages 415-420

  Kargi, Aydanur ^a   Gurel, Duygu ^a   Tuna, Burçin ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

CK5 6; Lung carcinoma; p63; TTF 1

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1;

ARTICLE; BRONCHOSCOPY; CANCER CLASSIFICATION; CANCER MORPHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

CARCINOMA; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATIN-6; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 37349100847     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31802fab75     Document Type: Article

References (28)

1. Travis WD, Colby TV, Corrin B, et al, in collaboration with Sobin LH and pathologists from 14 countries. WHO Histological typing of Lung and Pleural tumours. 3rd ed. Berlin: Springer; 1999.
2. Travis WD. Pathology of lung cancer. Clin Chest Med. 2002;23:65-81.
3. Vollmer RT, Ogden L, Crissman JD. Seperation of small-cell from non-small cell lung cancer. The Southeastern Cancer Study Group Pathologist' experience. Arch Pathol Lab Med. 1984;108:792-779.
4. Thomas J St J, Lamb D, Aschcroft T, et al. How reliable is the diagnosis of lung cancer using small biopsy specimans? Report of a UKCCCR Lung Cancer Working Part. Thorax. 1993;48:1135-1139.
5. Burnett RA, Howatson SR, Lang S, et al. Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens. J Clin Pathol. 1996;49:130-135.
6. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest. 2002;122:1037-1057.
7. Mountain CF, Lukeman JM, Hammar SP, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol. 1987;35:147-156.
8. Wu M, Wang B, Gil J, et al. P63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol. 2003;119:696-702.
9. Marson VJ, Mazieres J, Groussard O, et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology. 2004;45:125-134.
10. Zhang H, Liu J, Cagle PT, et al. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol. 2005;18:111-118.
11. Johannsen L. Histopathologic classification of lung cancer: relevance of cytokeratin and TTF-1 immunophenotyping. Ann Diagn Pathol. 2004;8:259-267.
12. Rossi G, Marchioni A, Milani M, et al. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung. Am J Clin Pathol. 2004;122:884-893.
13. Shtilbans V, Szporn AH, Wu M, et al. p63 immunostaining in destained bronchoscopic cytologic specimens. Diagn Cytopathol. 2005;32:198-203.
14. Wick MR. Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol. 2000;17:194-203.
15. Nakamura N, Miyagi E, Murata S, et al. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol. 2002;15:1058-1067.
16. Pelosi G, Fraggetta F, Pasini F, et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol. 2001;25:363-372.
17. Chang YL, Lee YC, Liao WY, et al. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer. 2004;44:149-157.
18. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol. 2002;10:97-102.
19. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology. 2000;36:8-16.
20. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol. 2003;34:597-604.
21. Wang BY, G?l J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-926.
22. Massion PP, Taflan PM, Jamshedur Rahman SM, et al. Significance of p63 amplification and over expression in lung cancer development and prognosis. Cancer Res. 2003;63:7113-7121.
23. Pelosi G, Pasini F, Olsen Stenholm C, et al. P63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol. 2002;198:100-109.
24. Sheikh HA, Fuhrer K, Cieply K, et al. P63 expression in assessment of bronchioloalveolar proliferations of the lung. Mod Pathol. 2004;17:1134-1140.
25. Au NH, Gown AM, Cheang M, et al. p63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol. 2004;12:240-247.
26. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122-132.
27. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnoses of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
28. Carella R, Deleonardi G, D'Errico A, et al. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis. Am J Surg Pathol. 2001;25:43-50.